Biotechnologists harness biological systems, organisms, and cellular components to develop products and technologies that improve health, agriculture, and industry. Their work spans genetic engineering, microbiology, cell culture, and bioinformatics, with applications ranging from creating more efficient crops to producing life-saving pharmaceuticals. By manipulating DNA and proteins, biotechnologists contribute to advancements in medicine, such as personalized therapies, regenerative treatments, and targeted drug delivery systems. Their efforts also play a major role in industrial biotechnology, helping to create environmentally friendly alternatives like biodegradable plastics and biofuels.
Collaboration is key to the success of biotechnologists, as they work closely with molecular biologists, chemical engineers, and data scientists to bring innovations from the lab to the real world. In the healthcare sector, they develop and refine diagnostic tools, therapeutic proteins, and vaccine technologies that are essential to modern medicine. Their involvement in research and development accelerates the pipeline from scientific discovery to commercial application, ensuring that innovations reach those who need them most. Moreover, biotechnologists contribute to food security and environmental sustainability by engineering drought-resistant crops and bio-remediation techniques. Their versatile skill set and interdisciplinary approach position them as key players in addressing global challenges. With science evolving rapidly, biotechnologists continue to shape a more sustainable, healthy, and innovative future.
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States
Title : Capillary electrophoresis for adjuvanted multivalent recombinant vaccine purity determination
Ashley Prout, Merck, United States
Title : Hypersensitivity and anti-SARS-COV-2 vaccination: A retrospective study of the year 2021 at the University Hospital Center of Tours (France)
Faure Quentin, The Savoie Metropolitan Hospital Center, France
Title : THE HPV vaccination program in Colombia. From a beautiful dream to a nightmare, but hopefully with a bright dawn.
Carlos Castro, Colombian League against cancer, Colombia